S1803 **SUSPENDED** (Upcoming Temporary Suspension 3/29/23 10:00 p.m. cst.)

Study Number: S1803 **SUSPENDED** (Upcoming Temporary Suspension 3/29/23 10:00 p.m. cst.)

This phase II trial studies how well daratumumab after a stem cell transplant works in treating patients with multiple myeloma. Monoclonal antibodies, such as daratumumab, may kill cancer cells that are left after chemotherapy.

Contact Person(s)

• MBMC, Brandi Koziatek, 314-996-5898

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.